Pandemic highlighted challenges of ATMP clinical trials in Europe
A conflict between European regulations governing clinical trials and those governing the use of genetically modified organisms (GMO) was distinctly exposed by the COVID-19 pandemic, Charlie Mortazavi said here at RAPS Euro Convergence.
Read the news published by RIS.WORLD on 16 May 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (7 novembre 2022). Pandemic highlighted challenges of ATMP clinical trials in Europe. ELSIBI. Consulté le 18 mars 2025 à l’adresse https://doi.org/10.58079/o64w